latest update:
[RxAtlas]

drug summary · 2 NDC codes

AMJEVITA 10 mg/.2mL

adalimumab-atto

HUMAN PRESCRIPTION DRUG record from the RxAtlas dataset, marketing status BLA. Facts and NDC codes below are exported values from the current release, not inferred or edited prose.

dataset id 121221NDC codes 2application BLA761024RxCUI —

Facts

Field definitions, types, and provenance rules are in the data dictionary.

generic nameadalimumab-atto
active ingredientsADALIMUMAB
dosage formINJECTION
routeSUBCUTANEOUS
strength10 mg/.2mL
marketing statusBLA
DEA schedulenot reported
application numberBLA761024
ATC codenot reported
RxCUInot reported
manufacturerAmgen, Inc
product typeHUMAN PRESCRIPTION DRUG
pharmacologic classAntibodies; Antibodies, Monoclonal [CS]; Monoclonal [CS]; Tumor Necrosis Factor Blocker [EPC]; Tumor Necrosis Factor Receptor Blocking Activity [MoA]

NDC codes

2 National Drug Codes are mapped to this product in the current release. Package descriptions are not part of the published export, so the NDC code is the canonical package identifier here.

NDCPackage description
55513-413—
55513041301—

Other adalimumab-atto products

6 other products in the current release publish the same generic name. Strength, dosage form, and labeler are what distinguish them.

Work with this record

  • Field definitions

    Types, scope, and provenance rules for every exported field.

  • REST API

    Query the same gate-backed records programmatically.

  • Evaluation sample

    Download a bounded slice before buying.

  • $29 API Pass

    Seven days of REST and MCP access to the full catalogue; credited toward the licence.